Buy Sun Pharma for approx. 14% gain ( Target 600 )
Updated
1.Sun Pharma broke above its 200 DMA and tested it back again on weekly chart.
2. It has broken out of two consolidations:
a. Long term consolidation from 2019
b. short term consolidation from April 2020
TARGET : 600
C.P : 525
STOP LOSS: 515
2. It has broken out of two consolidations:
a. Long term consolidation from 2019
b. short term consolidation from April 2020
TARGET : 600
C.P : 525
STOP LOSS: 515
Trade closed: stop reached
STOPPED OUT
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.